These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3480787)

  • 1. Ceftizoxime and cefoxitin susceptibility testing against anaerobic bacteria: comparison of results from three NCCLS methods and quality control recommendations for the reference agar dilution procedure.
    Jones RN; Barry AL; Fuchs PC; Allen SD
    Diagn Microbiol Infect Dis; 1987 Oct; 8(2):87-94. PubMed ID: 3480787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative antimicrobial activity of aminothiazolyl methoxyimino cephalosporins against anaerobic bacteria, including 100 cefoxitin-resistant isolates.
    Jones RN; Barry AL; Aldridge KE; Gerlach EH
    Diagn Microbiol Infect Dis; 1987 Nov; 8(3):157-63. PubMed ID: 3501976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on the in vitro activity of ceftizoxime and other cephalosporin/cephamycin antimicrobial agents against clinically significant anaerobic bacteria.
    Aldridge KE
    Clin Ther; 1990; 12 Suppl C():3-12. PubMed ID: 2202509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of broth disk elution methods for susceptibility testing of anaerobic bacteria with the newer beta-lactam antibiotics.
    Jorgensen JH; Redding JS; Howell AW
    J Clin Microbiol; 1986 Mar; 23(3):545-50. PubMed ID: 3514661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the susceptibility of anaerobes to cefoperazone, cefotaxime, and cefoxitin with the thioglycolate broth disk procedure.
    Zabransky RJ; Birk RJ; Kurzynski TA; Toohey KL
    J Clin Microbiol; 1986 Aug; 24(2):181-5. PubMed ID: 3745418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic- and method-dependent variation in susceptibility testing results of Bacteroides fragilis group isolates.
    Aldridge KE; Sanders CV
    J Clin Microbiol; 1987 Dec; 25(12):2317-21. PubMed ID: 3480894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of susceptibility results of the Bacteroides fragilis group and other anaerobes by traditional MIC results and statistical methods.
    Aldridge KE; Johnson WD
    J Antimicrob Chemother; 1997 Mar; 39(3):319-24. PubMed ID: 9096180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative activity of several beta-lactam antibiotics against anaerobes determined by two methods.
    Zabransky RJ; Birk RJ
    Clin Ther; 1987; 10(1):107-25. PubMed ID: 3450391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro activity of ceftizoxime, cefoperazone, and cefoxitin against anaerobic bacteria.
    Drulak MW; Chow AW
    Antimicrob Agents Chemother; 1981 Nov; 20(5):683-5. PubMed ID: 6275782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.
    Goldstein EJ; Citron DM
    J Clin Microbiol; 1988 Nov; 26(11):2361-6. PubMed ID: 3235664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro beta-lactam activity against aerobic and anaerobic surgical isolates.
    Edmiston CE; Krepel CJ; Clausz JC; Condon RE
    Diagn Microbiol Infect Dis; 1988 Feb; 9(2):105-13. PubMed ID: 3164263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cephalosporins/cephamycins with antianaerobic activity by integrating microbiologic and pharmacokinetic properties.
    Kays MB; White RL; Friedrich LV; Del Bene VE
    Clin Ther; 1991; 13(5):596-605. PubMed ID: 1799917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major methodology-dependent discordant susceptibility results for Bacteroides fragilis group isolates but not other anaerobes.
    Aldridge KE; Schiro DD
    Diagn Microbiol Infect Dis; 1994 Nov; 20(3):135-42. PubMed ID: 7874880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria.
    Zabransky RJ; Bobey DG; Barry AL; Allen SD; Fuchs PC; Gerlach EH; Thornsberry C; Sheikh W; Jones RN
    J Clin Microbiol; 1989 Jan; 27(1):190-1. PubMed ID: 2643621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic susceptibility testing of anaerobic organisms using the agar dilution method: comparison of three techniques.
    Wexler HM; Reeves D; Finegold SM
    Clin Ther; 1988; 10(6):747-60. PubMed ID: 3219688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of ceftizoxime against Bacteroides fragilis: comparison with benzylpenicillin, cephalothin, and cefoxitin.
    Eley A; Greenwood D
    Antimicrob Agents Chemother; 1981 Sep; 20(3):332-5. PubMed ID: 6272629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci.
    Jones RN; Barry AL; Packer RR
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):37S-46S. PubMed ID: 6086217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of in vitro methods for testing ceftriaxone against anaerobic bacteria, including quality control guidelines.
    Barry AL; Jones RN
    J Clin Microbiol; 1988 Apr; 26(4):776-7. PubMed ID: 2896669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality control criteria for testing the susceptibility of anaerobic bacteria to meropenem.
    Zabransky RJ; Bayola-Mueller L; Jenkins SG; Pitkin DR; Schreckenberger PC; Celig DM; Spiegel CA
    J Clin Microbiol; 1990 Dec; 28(12):2804-5. PubMed ID: 2280013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant results between the broth disk elution and broth microdilution susceptibility tests with Bacteroides fragilis group isolates.
    Aldridge KE; Henderberg A; Schiro DD; Sanders CV
    J Clin Microbiol; 1990 Feb; 28(2):375-8. PubMed ID: 2312684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.